Pimavanserin Treatment in TS

Clinical trial NCT04794413 · COMPLETED

Trial details

NCT number: NCT04794413
Sponsor: Joseph Jankovic
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Tourette Syndrome Tardive Dyskinesia

Start date: 2018-11-12
Primary completion: 2021-02-28
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.